Articles related to Family Medicine/General Practice

In an adaptive randomized trial of adults with long COVID, fluvoxamine modestly reduced fatigue and improved quality-of-life scores through 90 days, while metformin findings remained inconclusive after dose modification and early termination.

Extensively drug-resistant Shigella has increased in US surveillance, with sexual transmission emerging as an important route among some populations. Rising multidrug resistance may complicate treatment, although many infections remain self-limited.

Mayim Bialik reports prolonged gastrointestinal symptoms after one dose of an unnamed GLP-1 medication taken for autoimmune symptoms. Her account describes individual intolerance, not the frequency of severe reactions or evidence of autoimmune benefit.

ACP places estrogen-based therapy first in its pharmacologic pathway for menopausal vasomotor symptoms, with nonhormonal alternatives for contraindications or intolerance. Recommendation strength and evidence certainty vary, and long-term safety evidence remains limited.

In a secondary analysis of 371,038 U.S. adults, individuals reporting several cardiovascular disease (CVD) risk factors or established CVD reported less frequent whole-fruit consumption. The cross-sectional survey identified associations only and did not establish whether dietary behaviors preceded disease.

Children exposed to maternal Tdap vaccination had lower pertussis toxin and diphtheria antibody concentrations at ages 3 and 4, but their responses matched controls after a preschool DTaP booster in this small Finnish follow-up.